Therefore, NOTCH3 gene screening criteria should not be restricted to patients with high risk for CADASIL, especially those without typical imaging findings but presenting with early-onset stroke, a family history of stroke or dementia, and no hypertension. This evidence concerns the gene NOTCH3 and Stroke.